FDA Drug Recalls

Recalls / Class III

Class IIID-1187-2018

Product

Diltiazem HCl Extended-Release Capsules, USP 120 mg 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-05

Affected lot / code info
Batch code # 3093163, expiration date 04/2019

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.

Recalling firm

Firm
Mylan Pharmaceuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
781 Chestnut Ridge Rd, N/A, Morgantown, West Virginia 26505-2730

Distribution

Quantity
656 500-count bottles
Distribution pattern
Distributed Nationwide in the US

Timeline

Recall initiated
2018-08-07
FDA classified
2018-09-10
Posted by FDA
2018-09-19
Terminated
2019-08-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1187-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.